🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 2, Multi-Center, Randomized, Double-Masked\*, Active Controlled Stu...
Status
Completed
Location
Adverum Clinical Site
Start Date
2020-05-28
Trial ID
NCT04418427
Treatments Being Tested
This is a multi-center, randomized, double-masked, active-comparator-contro...
Status
Recruiting
Location
Adverum Clinical Site 245
Start Date
2026-03-16
Trial ID
NCT07482176
Treatments Being Tested
The purpose of this study is to evaluate safety, effectiveness and durabili...
Status
Recruiting
Location
Adverum site 126
Start Date
2026-06-02
Trial ID
NCT07630649
Treatments Being Tested
ADVM-022-07 is an observational long-term extension (OPTIC-EXT) study asses...
Status
Active Not Recruiting
Location
Adverum Clinical Site
Start Date
2020-12-14
Trial ID
NCT04645212
Treatments Being Tested
This is a prospective, observational study designed to evaluate the long-te...
Status
Active Not Recruiting
Location
Adverum Clinical Site
Start Date
2022-08-10
Trial ID
NCT05607810
Treatments Being Tested
This is a multi-center, randomized, double-masked, active-comparator-contro...
Status
Active Not Recruiting
Location
Adverum Clinical Site 223
Start Date
2025-02-28
Trial ID
NCT06856577
Treatments Being Tested
Neovascular or wet age-related macular degeneration (nAMD) is a degenerativ...
Status
Active Not Recruiting
Location
Adverum Clinical Site 178
Start Date
2022-08-23
Trial ID
NCT05536973
ADVM-022 (AAV.7m8-aflibercept) is a gene therapy product developed for the ...
Status
Completed
Location
Adverum Clinical Site
Start Date
2018-11-14
Trial ID
NCT03748784
Treatments Being Tested